William Blair & Company
CLVS

William Blair & Company’s Clovis Oncology, Inc. CLVS Stock Holding History

William Blair & Company’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-100,950
Closed -$586K – 1970
2021
Q2 		$586K Sell
100,950
-50,000
-33% -$293K ﹤0.01% 1096
2021
Q1 		$1.06M Buy
+150,950
New +$1.01M ﹤0.01% 876

Other funds holding CLVS

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

William Blair & Company's CLVS Position: Q3 2021 in Review

William Blair & Company sold out of Clovis Oncology, Inc. (CLVS) in Q3 2021, closing a stake of 100,950 shares — an estimated $586K sold.

William Blair & Company first reported a position in CLVS in Q1 2021 and held it in 2 quarters. The position peaked at $1.06M in Q1 2021. 157 funds tracked by Wall St. Rank hold CLVS as of Q3 2021.

  • William Blair & Company reported no remaining Clovis Oncology, Inc. position as of Q3 2021 after selling out during the quarter.
  • William Blair & Company sold 100,950 Clovis Oncology, Inc. shares in Q3 2021, an estimated $586K.
  • William Blair & Company first reported a position in Clovis Oncology, Inc. in Q1 2021 and held it in 2 quarters.
  • William Blair & Company's Clovis Oncology, Inc. position peaked at $1.06M in Q1 2021.
  • 157 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q3 2021.

Based on William Blair & Company's 13F filing for Q3 2021, filed 12 Nov 2021.